Accelerator provides this unprecedented collection of resources by establishing partnerships between top-tier investors, seasoned executive management, and several world-class research institutions, all of whom have experience in transforming a great idea into a viable commercial product. By lending their expertise to Accelerator’s portfolio companies, these industry leaders provide critical knowledge and resources that can help to streamline the development and commercialization of novel technologies and influence the rapidly evolving future of medicine and healthcare.
In addition to a proprietary pipeline of anchor investors and strategic stakeholders, Accelerator maintains access to leading global technologies and commercial opportunities developed at research institutions, universities and biotechnology companies around the world. This winning formula has allowed Accelerator to channel venture capital and unprecedented ground-up support to the most compelling investment opportunities.
In 2014, Accelerator expanded its scope of operations by opening a second operation in New York City. Accelerator’s startup development capabilities will thrive in New York City through partnerships that have been established between top-tier investors, seasoned executive management, and several world-class research institutions in New York City, all of whom have experience and capabilities that can be leveraged in helping to transform a great idea into a viable commercial product.
In selecting a location for expansion, Accelerator had three primary criteria: a critical mass of world-class research institutions; a relative lack of start-up capital for early-stage biotechnology opportunities; and the ability to seamlessly leverage our management team and capabilities to help companies that we fund. It became obvious to all of us that New York City would serve as the ideal location to scale our operations, and we could not be more excited by the opportunity that we have before us to support the development of a vibrant life science ecosystem in New York City. In addition, Accelerator will work in partnership with seven top-tier institutions, including Albert Einstein College of Medicine of Yeshiva University, Columbia University, Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, New York University, The Rockefeller University, and Weill Cornell Medical College. Through this collaboration, we will have a unique opportunity to access some of the region’s most promising opportunities and collaborate with some of the world’s thought leaders in a variety of scientific disciplines that will be relevant to Accelerator.